$TMO (Thermo Fisher Scientific, Inc.)

$TMO {{ '2015-07-22T15:36:48+0000' | timeago}} • Webcast

$TMO 2Q15 Call: Cash flow from continuing operations for the first half of the year was $849MM & free cash flow was $663MM after deducting net capital expenditures of $186MM, about $160MM lower than the first half of 2014, primarily driven by a volume related working capital investments and the timing of interest and tax payments.

$AQUA {{ '2018-01-10T13:54:54+0000' | timeago}} • Announcement

$AQUA, which provides water treatment solutions, has appointed Peter Wilver to its board of directors. Wilver, a former senior executive at $TMO, most recently served as Thermo Fisher's EVP and Chief Administrative Officer. Earlier, he held financial management roles at various industrial companies including GE, Honeywell and Grimes Aerospace.

$TMO {{ '2018-01-09T12:43:22+0000' | timeago}} • Announcement

$TMO, a leading medical technology company, has signed an agreement with life sciences firm $ILMN, under which Thermo Fisher will provide Illumina with Ion AmpliSeq technology. The tie-up will help Illumina effectively sell Ion AmpliSeq technology to researchers engaged in scientific studies on its next-generation sequencing (NGS) platforms.

$TMO {{ '2017-11-22T16:06:12+0000' | timeago}} • Announcement

$TMO has received an unsolicited offer from TRC Capital to purchase up to one million shares of the company’s common stock for $181.75 per share in cash. According to Thermo Fisher, the offer price is about 4.43% lower than the closing price of its stock on November 17, 2017. The offer accounts for about 0.249% of the company’s outstanding shares.

$TMO {{ '2017-11-10T12:00:35+0000' | timeago}} • Announcement

$TMO has declared a quarterly cash dividend of $0.15 per share on its common stock. The dividend will be paid on January 15, 2018, to shareholders of record as of December 15, 2017.

$TMO {{ '2017-10-25T17:31:21+0000' | timeago}} • Infographic

$TMO Thermo Fisher Scientific Earnings AlphaGraphic: Q3 2017 Highlights

$TMO {{ '2017-10-25T15:46:47+0000' | timeago}} • Webcast

$TMO said it expects to return a total of about $240MM in capital to shareholders in fiscal 2017, entirely through dividends, with no additional share buybacks planned for the rest of the year.  Thermo Fisher anticipates to generate $3.5Bil of free cash flow in 2017, which is in line with its previous estimate.

$TMO {{ '2017-10-25T15:15:36+0000' | timeago}} • Webcast

$TMO said pursuant to the acquisition of Patheon, around 9,000 employees of that company joined the Thermo Fisher team in the third quarter. Following completion, the transaction is expected to bring in total synergies of about $120MM in three years, comprising $90MM of cost synergies and $30MM of adjusted operating income benefit.

$TMO {{ '2017-10-25T14:50:44+0000' | timeago}} • Webcast

$TMO said it continues to focus on the 3-pronged growth strategy of developing high-impact innovative products, leveraging the scale in emerging markets and delivering value proposition to customers. During third quarter, the company launched two new electron microscopes for Materials Sciences and Applications and four Thermo Scientific products.

$TMO {{ '2017-10-25T11:25:43+0000' | timeago}} • Announcement

Revenues of $TMO’s Life Sciences Solutions segment grew 5% YoY to $1.38Bil in 3Q17. Supported by contributions from the recently acquired FEI Company, Analytical Instruments revenue jumped 32%. Revenues of the Specialty Diagnostics division and Laboratory Products/Services segment gained 6% and 15%, respectively, compared to last year.

$TMO {{ '2017-10-25T11:09:03+0000' | timeago}} • Announcement

Reflecting its recent acquisitions and an improved forex environment, $TMO upgraded its FY17 revenue estimate to the range of $20.5Bil to $20.66Bil from the previous guidance of $19.71-$19.89Bil, which will result in a 12-13% YoY growth. The adj. EPS outlook has been revised up to the $9.29-$9.38 range from $9.15-$9.28 the company expected earlier.

$TMO {{ '2017-10-25T10:58:03+0000' | timeago}} • Announcement

Medical instruments maker $TMO reported a 14% annual growth in 3Q17 revenues to $5.1Bil, supported by contributions from recent acquisitions and favorable currency values. Net income gained 13%, and earnings per share moved up to $1.34 from $1.19 last year.  Adjusted earnings rose to $2.31 per share and beat estimates, continuing the recent trend.

$TMO {{ '2017-08-29T13:21:17+0000' | timeago}} • Announcement

$TMO said it completed the acquisition of $PTHN for approx. $7.2Bil. For the remainder of 2017, the transaction is expected to be approx. $0.09 accretive to adjusted EPS, which includes $0.02 in 3Q17.

$TMO {{ '2017-08-23T20:33:41+0000' | timeago}} • Announcement

$TMO, a biotech company, announced that all required antitrust clearances have been obtained for the previously announced all-cash tender offer by its wholly owned subsidiary, Thermo Fisher (CN) Luxembourg, to purchase all of the outstanding ordinary shares of $PTHN, a pharma company. The firm expects to complete the tender offer on Aug 28, 2017.

$TMO {{ '2017-08-11T12:09:46+0000' | timeago}} • Announcement

$TMO has priced an offering of $750MM aggregate principal amount of its 3.2% senior notes due 2027 and $750MM aggregate principal amount of 4.1% senior notes due 2047. The offer is expected to close on August 14. The company intends to use the proceeds of the offering to fund a portion of the consideration payable for the acquisition of $PTHN.

$TMO {{ '2017-08-09T18:26:30+0000' | timeago}} • Announcement

$TMO priced its underwritten public offering of 8.77MM shares of common stock at $171 per share for gross proceeds of approx. $1.5Bil. The underwriters are given 30-day option to purchase 1.32MM more shares. The issue will end on Aug 11, 2017. A portion of its acquisition of $PTHN, to be closed by 3Q17-end, will be funded with the proceeds.

$TMO {{ '2017-08-07T20:44:48+0000' | timeago}} • Announcement

$TMO's subsidiary Thermo Fisher (CN) Luxembourg has extended the offering period of its all-cash tender offer to buy all of outstanding ordinary shares of $PTHN. $TMO now expects to complete the transaction around the end of 3Q17. The tender offer is now scheduled to expire on Aug. 28, 2017, unless extended or earlier terminated.

$TMO {{ '2017-08-07T20:32:39+0000' | timeago}} • Announcement

$TMO has commenced an underwritten public offering of $1.5Bil of its common stock. The company plans to use the net proceeds from the offering to fund a portion of the consideration payable for the acquisition of $PTHN, including repayment of Patheon’s debt. The acquisition is expected to close by the end of 3Q17.

$TMO {{ '2017-07-26T14:06:23+0000' | timeago}} • Webcast

$TMO said the upward revision of 2017 financial outlook mainly reflected the less adverse foreign exchange environment. The company continues to expect 4% organic revenue growth for the year. Excluding the effect of foreign exchange headwinds, adjusted EPS is seen growing 12-14%. Adjusted operating margin is forecast to grow 50-60 basis points YoY.

$TMO {{ '2017-07-26T13:46:17+0000' | timeago}} • Webcast

Scientific equipment maker $TMO said pharma and biotec continued to be its strongest end markets in 2Q17, with mid-single digits growth. The company's growth strategy remains centered on launching innovative products and leveraging the scale in Asia Pacific and emerging markets. In 2Q17, Thermo Fisher completed $250MM of share buybacks.

$TMO {{ '2017-07-26T12:48:19+0000' | timeago}} • Infographic

$TMO Thermo Fisher Scientific, Inc. Earnings AlphaGraphic: Q2 2017 highlights

Recent Transcripts

KBH (KB Home)
Wednesday, January 10 2018 - 10:00pm
DE (Deere & Company)
Wednesday, November 22 2017 - 3:00pm
JHX (James Hardie Industries plc)
Wednesday, November 8 2017 - 11:00pm
VRML (Vermillion, Inc.)
Wednesday, November 8 2017 - 9:30pm
MYGN (Myriad Genetics, Inc.)
Tuesday, November 7 2017 - 9:30pm
QGEN (Qiagen NV)
Tuesday, November 7 2017 - 2:00pm
HY (Hyster-Yale Materials Handling, Inc.)
Friday, November 3 2017 - 3:00pm
MTD (Mettler-Toledo International Inc.)
Thursday, November 2 2017 - 9:00pm
KEM (KEMET Corp.)
Thursday, November 2 2017 - 1:00pm
ITT (ITT Corporation)
Thursday, November 2 2017 - 1:00pm
AME (Ametek Inc.)
Thursday, November 2 2017 - 12:30pm
KMT (Kennametal Inc.)
Thursday, November 2 2017 - 12:00pm
GPRO (GoPro, Inc.)
Wednesday, November 1 2017 - 9:00pm
KAI (Kadant Inc.)
Tuesday, October 31 2017 - 3:00pm
SNE (Sony Corporation)
Tuesday, October 31 2017 - 7:30am
IMAX (IMAX Corporation)
Thursday, October 26 2017 - 12:30pm
APH (Amphenol Corporation)
Wednesday, October 25 2017 - 5:00pm
IR (Ingersoll-Rand Plc)
Wednesday, October 25 2017 - 2:00pm
LEA (Lear Corp.)
Wednesday, October 25 2017 - 1:00pm
TMO (Thermo Fisher Scientific, Inc.)
Wednesday, October 25 2017 - 12:30pm

AlphaGraphics you may like